Breaking India News Today | In-Depth Reports & Analysis – IndiaNewsWeekBreaking India News Today | In-Depth Reports & Analysis – IndiaNewsWeek
  • Home
  • Nation
  • Politics
  • Economy
  • Sports
  • Entertainment
  • International
  • Technology
  • Auto News
Reading: Barriers to Affordable Medicines: The Tension Between Free Markets and Accessibility
Share
Breaking India News Today | In-Depth Reports & Analysis – IndiaNewsWeekBreaking India News Today | In-Depth Reports & Analysis – IndiaNewsWeek
  • Home
  • Nation
  • Politics
  • Economy
  • Sports
  • Entertainment
  • International
  • Technology
  • Auto News
© 2024 All Rights Reserved | Powered by India News Week
Trending Now: Stay updated with the latest breaking news from India and around the world
‘Free markets’ and shackled access to medicines
Breaking India News Today | In-Depth Reports & Analysis – IndiaNewsWeek > Economy > Barriers to Affordable Medicines: The Tension Between Free Markets and Accessibility
Economy

Barriers to Affordable Medicines: The Tension Between Free Markets and Accessibility

Indianewsweek By Indianewsweek May 10, 2026 4 Min Read
Share
SHARE

Billions worldwide, including in India, cannot access affordable medications. In the U.S., nearly one in three citizens struggles to afford prescription drugs. Pharmaceutical companies often delay the launch of new products in Europe due to the region’s efforts to control drug prices. The impact of the COVID-19 pandemic and rising living costs has intensified scrutiny of the pharmaceutical system as prescription drug prices soar. However, discussions about the causes and potential policy solutions frequently overlook the “rules” underpinning these challenges and the necessity of breaking free from them.

The newly published book Pharma Monopoly: The Battle for the Future of Medicines, co-authored with Rohit Malpani, examines how the neoliberal political economy and the western pharmaceutical industry have utilized concepts like “free markets,” “competition,” and “innovation” to create a facade of a “rules-based” order. This order has facilitated the globalization of trade and the intellectual property (IP) system under the World Trade Organization’s (WTO) Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreement.

Over recent decades, the global IP framework has granted pharmaceutical corporations substantial control. Consequently, global health initiatives and philanthropic efforts often seek industry permission to access medicines rather than addressing the structural injustices and failures within the system.

India has historically resisted the “rules-based” TRIPS order, maintaining its role as the “pharmacy of the poor.” The country demonstrated leadership by introducing provisions such as Section 3(d) in its amended Patent Law (2005) to counteract the western pharmaceutical industry’s practice of extending patent protections unjustly. India co-sponsored a waiver of IP rights under the TRIPS agreement during the COVID-19 pandemic. Despite these initiatives, India’s policies over the last two decades have increasingly aligned with the neoliberal ideologies it once opposed. Many generic manufacturers now comply with the “voluntary” patent licenses prescribed by pharmaceutical firms to avoid straining relationships with the Global North.

As the United States—historically a proponent of neoliberalism—shifts away from globalization, the power dynamics are revealing themselves without the facade of a rules-based order. In this context, countries, particularly those in the Global South, are reconsidering their positions and seeking new alliances.

Despite the uncertainties ahead, this moment presents an opportunity for countries like India to create a trade system reminiscent of the New International Economic Order envisioned in the 1970s, which prioritized economic justice.

Ultimately, communities, civil society, and governments must cease relying on the pharmaceutical industry and existing power structures to reform themselves. Instead, they need to forge a new path that prioritizes access to medicines for all. It is critical to avoid the allure of incremental changes that detract from achieving systemic reforms that can enhance public welfare. The long struggle toward a future where everyone has the right to access medicines must be embraced.

—Tahir Amin, Co-Founder and CEO, Initiative for Medicines, Access & Knowledge

TAGGED:Economy NewsNews
Share This Article
Twitter Copy Link
Previous Article POCO X8 Pro review: Speed meets style POCO X8 Pro Review: Unleashing Style and Speed in a Competitive Smartphone Market
Next Article Congress hunts for consensus as camps flex muscle in CM battle: What’s happening Kerala Kerala’s CM Showdown: Congress Strives for Unity Amid Rising Tensions Between Rival Factions
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Latest News

Stock Market Today Live, Nov 16: Sensex, Nifty pare early gains as investors assess sustainability of market rally

Market Update: Sensex and Nifty Trim Early Gains Amid Investor Concerns on Rally Longevity

November 16, 2026
Mahindra's electric three-wheeler arm eyes IPO in 18 months

Mahindra’s Electric Three-Wheeler Division Plans IPO Within 18 Months Amid Growing Demand

November 16, 2026
Photos: Pope Leo visits Peru’s Amazon and Andean regions during 12-day tour

Pope Leo Embarks on 12-Day Tour of Peru’s Amazon and Andean Regions

November 16, 2026
SEBI bars EKI Energy MD Manish Dabkara for 12 months over financial misrepresentation

SEBI Suspends EKI Energy’s Manish Dabkara for 12 Months Due to Financial Misrepresentation

November 1, 2026
A cure for Trump? Why Democratic doctors are running in the 2026 midterms

Democratic Doctors Aim to Counter Trump Influence in 2026 Midterms

November 1, 2026
Tech Query: ICICI Prudential Asset Management Company (AMC), Latent View Analytics, Rashtriya Chemicals and Fertilizers, IRB Infrastructure Developers — What is the outlook? Where are these stocks headed? 

Market Outlook: Future Prospects for Sundram Fasteners, HDB Financial, Sterlite Tech, and Techno Electric

October 31, 2026

You Might Also Like

Mandaviya seeks investment budget pushed to ₹15 lakh cr/yr to realise Viksit Bharat & social security for all
Nation

Mandaviya Advocates ₹15 Lakh Crore Annual Investment for Viksit Bharat and Universal Social Security

4 Min Read
Women shine in the 21K in the 30–39 age category with balance and consistency
Nation

Women excel in 21K race, showcasing balance and consistency in 30-39 age group

2 Min Read
Markets set to open lower as rising oil prices dampen sentiment
Economy

Markets Expected to Decline as Soaring Oil Prices Weigh on Investor Sentiment

2 Min Read
NSE changes expiry of all F&O contracts to Monday from April 4
Economy

NSE to Move F&O Contract Expiry to Monday Starting April 4

2 Min Read

About IndiaNewsWeek

IndiaNewsWeek is your trusted source for breaking news, in-depth analysis, and comprehensive coverage of India and the world. We deliver accurate, timely reporting across politics, economy, sports, entertainment, and technology.

contact@indianewsweek.com

Quick Links

  • Nation
  • Politics
  • Economy
  • International
  • Sports
  • Entertainment

More Sections

  • Technology
  • Auto News
  • Education
  • About Us
  • Contact
  • Privacy Policy

Stay Connected

Follow us on social media for the latest updates and breaking news.

Facebook
X (Twitter)
YouTube
Follow US
© 2026 IndiaNewsWeek. All Rights Reserved.
Welcome Back!

Sign in to your account

Lost your password?